4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001415889-22-000439
Options or other derivatives
- Director acquired 26,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Xu Yuan Director | 2022-01-04 | Grant or award · Stock Option (right to buy) | +26,400 | 26,400 | D | ||
Loading xslF345X03/form4-01062022_030116.xml…